Derek Cole
Head of Investor Relations, Y3 Solutions
Replay available
Longeveron Inc. (LGVN) Q1 2026 Earnings Call
Longeveron Inc. (NASDAQ: LGVN) Q1 2026 earnings conference call, held 2026-05-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Stephen Willard
Chief Executive Officer
Natalia Agafonova
Chief Medical Officer
Lisa Locklear
Chief Financial Officer
Joshua Herr
Co-Founder, Chief Science Officer & Executive Chairman
Raj Salvaraju
Analyst, HC Wainwright
Manasa Daringan
Analyst, Roth Capital Partners
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Longeveron Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.357 Ladies and gentlemen, greetings and welcome to the Longevron 2026 first quarter 00:00:05.357 -- 00:00:08.621 financial results and business update call. 00:00:08.621 -- 00:00:12.024 At this time, all participants are in listen-only mode. 00:00:12.024 -- 00:00:16.409 A brief question and answer session will follow the formal presentation. 00:00:16.409 -- 00:00:20.594 If anyone requires operator assistance during the conference call, please signal the 00:00:20.594 -- 00:00:25.439 operator by pressing star and zero on your telephone keypad. 00:00:25.439 -- 00:00:29.022 As a reminder, this conference is being recorded. 00:00:29.022 -- 00:00:33.426 It is now my pleasure to introduce your host, Derek Cole, from Investor Relations at 00:00:33.426 -- 00:00:37.148 Y3 Solutions. Please go ahead. 00:00:37.951 -- 00:00:41.854 Thank you, Operator. Good afternoon, everyone, and thank you for joining us today to 00:00:41.854 -- 00:00:47.060 review Longevron's 2026 First Quarter Financial Results and Business Update. 00:00:47.060 -- 00:00:50.743 After the U.S. markets today, we issued a press release with financial results for the 00:00:50.743 -- 00:00:55.708 first quarter, which can be found under the Investor section of the Longevron website. 00:00:55.708 -- 00:01:00.917 On the call today are Stephen Willard, Chief Executive Officer, Joshua Herr, Co-Founder, 00:01:00.917 -- 00:01:06.023 Chief Science Officer and Executive Chairman of the Board, Natalia Agafonova, Chief Medical 00:01:06.023 -- 00:01:09.408 Officer, and Lisa Locklear, Chief Financial Officer. 00:01:09.408 -- 00:01:13.272 As a reminder, during this call, we will be making forward-looking statements. 00:01:13.272 -- 00:01:17.037 These statements are subject to certain risks and unce...